News

Researchers from VU Amsterdam demonstrate how a new method allows surgeons to identify brain tumours in real time.

The company is leveraging its material and polymer expertise to expand into the life sciences industry in the two major industry categories of bioprocessing and diagnostic and research products.

UCSF researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are.

Collaboration aims to establish strong research and learning foundations for Chinese medicine at the local and regional levels.

Quest Diagnostics has announced that it has expanded its chronic hepatitis C virus (HCV) test services to include new capabilities to help physicians identify or predict resistance to several HCV therapies.

Study traces how a largely unfamiliar pathogen led to a global epidemic.

Company has announced partnership with Leica Biosystems for development of a heregulin companion diagnostic assay for Seribantumab.

Company has announced that the U.S. FDA has approved the Company’s lead product, Epi proColon®, blood-based colorectal cancer screening test.

A signaling molecule called interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients.

Illumina will commit $100M over 10 years to drive genomic technology development.